Global Endotracheal Tube Market, by Product Type (Cuffed, Uncuffed, Armored/Reinforced, Others) by Route (Orotracheal, Nasotracheal) by End User (Hospitals, Ambulatory Surgical Center, Other and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 920.0 Million in 2023 and is expected to exhibit a CAGR of 6.6% during the forecast period (2023-2030), as highlighted in a new report published by Coherent Market Insights.
The key market players in the market are focusing on the adoption of organic growth strategies, such as product launches to expand their product portfolio, which is expected to drive market growth over the forecast period. For instance, on August 2, 2019, Jiangxi Yikang Medical Instrument Group Co., Ltd company launches the Yikang Endotracheal Tube product. The device is used for oral or nasal intubation and for airway management.
Global Endotracheal Tube Market– Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2019 as "coronavirus disease 2019" or COVID-19. This virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries such as India, China, Brazil, and others faced problems with regard to the transportation of drugs from one place to another.
COVID-19 had a negative impact on the global endotracheal tube market. For instance, in June 2022, the COVID-19 outbreak led to 80,409 diagnosed cases and 3,012 deaths in mainland China based on the data released on March 4, 2020. Approximately 3.2% of patients with COVID-19 required intubation and invasive ventilation at some point in the disease course.
Global Endotracheal Tube Market: Key Developments
Bactiguard develops and supplies infection prevention solutions. The Bactiguard technology reduces the risk of healthcare infections such as Ventilator-Associated Pneumonia, microbial adhesion to the surface of medical devices. In 2019, The company announces the launch of its new BIP Endotracheal Tube Evac, for the prevention of ventilator-associated pneumonia (VAP). It is one of a kind and designed to offer the best infection protection available on the market. VAP is the second most common nosocomial infection in the ICU and is associated with high-risk pathogens such as MRSA, prolonged hospital stay, increased hospital costs, and high patient mortality.
On November 23, 2020, the Medical Research Council accelerated the development of the world's first optical fiber sensor-equipped endotracheal tube (iTraXS). iTraXS aims to prevent pressure injury to the airway and to assist with monitoring vital signs. The device successfully monitors both the contact pressure and the blood supply at the cuff-trachea interface (the point where the cuff touches the windpipe lining) to ensure a good gas seal while avoiding windpipe injury.
Browse 34 Market Data Tables and 30 Figures spread through 183 Pages and in-depth TOC on “Global Endotracheal Tube Market”- Forecast to 2030, Global Endotracheal Tube Market, by Product Type (Cuffed, Uncuffed, Armored/Reinforced, Others) by Route (Orotracheal, Nasotracheal) by End User (Hospitals, Ambulatory Surgical Center, Other), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/insight/endotracheal-tube-market-2564/toc
Key Takeaways of the Global Endotracheal Tube Market:
- The global endotracheal tube market is expected to exhibit a CAGR of 6.6% during the forecast period due to the increasing emergence of COVID-19. For instance, in April 2020, a team at the Perelman School of Medicine at the University of Pennsylvania launched the U.S. component of a global registry that aims to help protect healthcare providers who intubate patients with COVID-19. As per the observation placing a breathing tube in patients with COVID-19 can pose a high risk to healthcare workers, as it may expose them to aerosols and droplets from a patient’s airways.
- Among end users, the hospital segment is estimated to hold a dominant position in the global endotracheal tube market over the forecast period. For instance, due to the improvement in the technological advancement of coated endotracheal tubes, the increase in the incidence of ventilator-associated pneumonia, and awareness about the endotracheal tube is projected to drive the global coated endotracheal tube market.
- Among region, North America is expected to be the dominant region in the global endotracheal tube market, which is expected to drive the segment growth over the forecast period. For instance, 93 patients (42 men and 51 women) undergoing elective surgery with general endotracheal anesthesia from three hospitals in Louisville, Kentucky: 41 patients from University Hospital (an academic center), 32 from Jewish Hospital (a private hospital), and 20 from Norton Hospital (also a private hospital). Cuff pressure in endotracheal (ET) tubes should be in the range of 20–30 cm H2O but as per the results shows only 27% of the patients had measured pressures within the recommended range of 20–30 cm H2O.
- Major players operating in the global endotracheal tube market include Medtronic Plc, Teleflex Inc., ConvaTec Inc., Smiths Medical, Neurovision Medical Products, Intersurgical Inc., Royax, Novo Klinik-Service GmbH, Avanos Medical, Inc., Bactiguard, and N8 Medical LLC.
